Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantina Karamanou

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Seminars in Cancer Biology|August 12, 2019
Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulatorKonstantina Karamanou, Marco Franchi, Demitrios Vynios, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 11, 2018
Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in CancerZoi Piperigkou, Dimitra Manou, Konstantina Karamanou, et al.
Advanced Drug Delivery Reviews|March 5, 2018
Lumican as a multivalent effector in wound healingKonstantina Karamanou, Gwenn Perrot, Francois-Xavier Maquart, et al.
Molecules (Basel, Switzerland)|July 24, 2021
Updating Insights into the Catalytic Domain Properties of Plant <i>Cellulose synthase</i> (<i>CesA</i>) and <i>Cellulose synthase-like</i> (<i>Csl</i>) ProteinsGerasimos Daras, Dimitris Templalexis, Fengoula Avgeri, et al.
Cells|April 30, 2021
Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia MarkersKonstantina Karamanou, Marco Franchi, Isabelle Proult, et al.
Glycoconjugate Journal|September 12, 2016
Biological function of unique sulfated glycosaminoglycans in primitive chordatesKonstantina Karamanou, Diana Carolina Restrepo Espinosa, Anneliese Fortuna-Costa, et al.
The FEBS Journal|March 12, 2020
Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signalingKonstantina Karamanou, Marco Franchi, Maurizio Onisto, et al.
Glycoconjugate Journal|October 26, 2016
The role of heparins and nano-heparins as therapeutic tool in breast cancerNikos A Afratis, Konstantina Karamanou, Zoi Piperigkou, et al.
The FEBS Journal|July 22, 2014
Epigenetics in extracellular matrix remodeling and hyaluronan metabolismDavide Vigetti, Manuela Viola, Evgenia Karousou, et al.
Scientific Reports|March 24, 2017
Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transitionKonstantina Karamanou, Marco Franchi, Zoi Piperigkou, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Seminars in Cancer Biology|August 12, 2019
Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulatorKonstantina Karamanou, Marco Franchi, Demitrios Vynios, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 11, 2018
Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in CancerZoi Piperigkou, Dimitra Manou, Konstantina Karamanou, et al.
Advanced Drug Delivery Reviews|March 5, 2018
Lumican as a multivalent effector in wound healingKonstantina Karamanou, Gwenn Perrot, Francois-Xavier Maquart, et al.
Molecules (Basel, Switzerland)|July 24, 2021
Updating Insights into the Catalytic Domain Properties of Plant <i>Cellulose synthase</i> (<i>CesA</i>) and <i>Cellulose synthase-like</i> (<i>Csl</i>) ProteinsGerasimos Daras, Dimitris Templalexis, Fengoula Avgeri, et al.
Cells|April 30, 2021
Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia MarkersKonstantina Karamanou, Marco Franchi, Isabelle Proult, et al.
Glycoconjugate Journal|September 12, 2016
Biological function of unique sulfated glycosaminoglycans in primitive chordatesKonstantina Karamanou, Diana Carolina Restrepo Espinosa, Anneliese Fortuna-Costa, et al.
The FEBS Journal|March 12, 2020
Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signalingKonstantina Karamanou, Marco Franchi, Maurizio Onisto, et al.
Glycoconjugate Journal|October 26, 2016
The role of heparins and nano-heparins as therapeutic tool in breast cancerNikos A Afratis, Konstantina Karamanou, Zoi Piperigkou, et al.
The FEBS Journal|July 22, 2014
Epigenetics in extracellular matrix remodeling and hyaluronan metabolismDavide Vigetti, Manuela Viola, Evgenia Karousou, et al.
Scientific Reports|March 24, 2017
Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transitionKonstantina Karamanou, Marco Franchi, Zoi Piperigkou, et al.
Pageof 2